x
Filter:
Filters applied
- Regular Research Articles
- phosphatidylethanolamineRemove phosphatidylethanolamine filter
- phosphatidylinositolRemove phosphatidylinositol filter
- GPLRemove GPL filter
Publication Date
Please choose a date range between 2021 and 2022.
Author
- Ackerman, Jacobo Miranda1
- Blanksby, Stephen J1
- Bowman, Andrew P1
- Brosch, Mario1
- Buch, Stephan1
- Coskun, Ünal1
- Ellis, Shane R1
- Gross, Justus1
- Gunter, Jennifer H1
- Hampe, Jochen1
- Hartler, Jürgen1
- Has, Canan1
- Heeren, Ron MA1
- Klipp, Edda1
- Knittelfelder, Oskar1
- Köfeler, Harald C1
- Nelson, Colleen C1
- Palladini, Alessandra1
- Pauling, Josch Konstantin1
- Philp, Lisa K1
- Poad, Berwyck LJ1
- Rose, Tim Daniel1
- Röcken, Christoph1
- Sadowski, Martin C1
- Schafmayer, Clemens1
Regular Research Articles
2 Results
- Research ArticleOpen Access
Isomeric lipid signatures reveal compartmentalized fatty acid metabolism in cancer
Journal of Lipid ResearchVol. 63Issue 6100223Published online: May 7, 2022- Reuben S.E. Young
- Andrew P. Bowman
- Kaylyn D. Tousignant
- Berwyck L.J. Poad
- Jennifer H. Gunter
- Lisa K. Philp
- and others
Cited in Scopus: 5The cellular energy and biomass demands of cancer drive a complex dynamic between uptake of extracellular FAs and their de novo synthesis. Given that oxidation of de novo synthesized FAs for energy would result in net-energy loss, there is an implication that FAs from these two sources must have distinct metabolic fates; however, hitherto, all FAs have been considered part of a common pool. To probe potential metabolic partitioning of cellular FAs, cancer cells were supplemented with stable isotope-labeled FAs. - Research ArticleOpen Access
Nonalcoholic fatty liver disease stratification by liver lipidomics
Journal of Lipid ResearchVol. 62100104Published online: August 9, 2021- Olga Vvedenskaya
- Tim Daniel Rose
- Oskar Knittelfelder
- Alessandra Palladini
- Judith Andrea Heidrun Wodke
- Kai Schuhmann
- and others
Cited in Scopus: 18Nonalcoholic fatty liver disease (NAFLD) is a common metabolic dysfunction leading to hepatic steatosis. However, NAFLD's global impact on the liver lipidome is poorly understood. Using high-resolution shotgun mass spectrometry, we quantified the molar abundance of 316 species from 22 major lipid classes in liver biopsies of 365 patients, including nonsteatotic patients with normal or excessive weight, patients diagnosed with NAFL (nonalcoholic fatty liver) or NASH (nonalcoholic steatohepatitis), and patients bearing common mutations of NAFLD-related protein factors.